Web NewDrugInformation.com

Lidex-e Drug - Lidex-e The trade name of the product as shown on the labeling. Dosage - CREAM; TOPICAL The product dosage form and route separated by a semi-colon. Active Ingredient(s) - Fluocinonide Multiple ingredients are in alphabetical order. Strength - 0.05% The potency of the active ingredient(s), Fluocinonide. May repeat for multiple part products. Applicant - MEDICIS The firm name holding legal responsibility for Lidex-e. The firm name is condensed to a maximum twenty character unique string. New Drug Application (NDA) Number - 016908 The FDA assigned number to Lidex-e. Format is nnnnnn. Product Number - 003 The FDA assigned number to identify Lidex-e. Each strength is a separate product. May repeat for multiple part products. Format is nnn. Therapeutic Equivalence (TE) Code - AB2 The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products. Approval Date - Approved Prior to Jan 1, 1982 The date Lidex-e was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982". Reference Listed Drug (RLD) - Yes The pioneer or innovator of Lidex-e. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No. Type - RX The group or category of approved drugs Lidex-e is in. Format is RX, OTC, DISCN. Applicant Full Name - Medicis Pharmaceutical Corp The full name of the firm holding legal responsibility for the new application of Lidex-e. Lidex-e Fluocinonide Emulsified Base 0.05% Cream; Topical Fluocinonide Emulsified Base 0.05% Cream; Topical Fluocinonide Emulsified Base 0.05% Cream; Topical Lidex 0.05% Cream; Topical Lidex-e 0.05% Cream; Topical Fluocinonide 0.05% Cream; Topical Fluocinonide 0.05% Cream; Topical Fluocinonide 0.05% Cream; Topical Fluocinonide 0.05% Cream; Topical Fluocinonide Emulsified Base 0.05% Cream; Topical NewDrugInformation